Tumour Virus Research impact factor, indexing, ranking (2022)


Tumour

Aim and Scope

Tumour Virus Research is a research journal that publishes research related to Infectious Diseases. This journal is published by Elsevier. The P-ISSN of this journal is 26666790.

Also, check the other important details below like Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate of Tumour Virus Research.

Tumour Virus Research Ranking

Impact Factor: N/A
Total Citations: 16
SJR (SCImago Journal Rank): 0
Quartile: Q1

The Impact Factor of Tumour Virus Research is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title: Tumour Virus Research
Publisher: Elsevier
P-ISSN: 26666790
Open Access: YES
Subject: Infectious Diseases
Citescore: 6
SNIP: 0
SJR: 0
Quartile: 1

Tumour Virus Research Indexing

The Tumour Virus Research is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.


Tumour Virus Research Impact Factor 2022

The latest impact factor of Tumour Virus Research is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.


Tumour Virus Research Quartile

The latest Quartile of Tumour Virus Research is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Publication fee

Based on the Official Journal Homepage, the publication fee of Tumour Virus Research is around 900 USD.

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Tumour Virus Research?

This journal covers the fields/ categories related to Infectious Diseases. If your research field is related to Infectious Diseases, then visit the official website of Tumour Virus Research and send your manuscript.

Tips for publishing in Tumour Virus Research:

  • Selection of research problem.
  • Presenting a solution.
  • Designing the paper.
  • Make your manuscript publication worthy.
  • Write an effective results section.
  • Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Even you can Contact the editor of the journal.

Journal Review Time

Journals usually ask reviewers to provide their reviews within 3-4 weeks. However, few journals have a mechanism to enforce the deadline, which is why it can be hard to predict how long the peer review process will take.

The review time also depends upon the quality of a research paper.


Final Summary

  • The impact factor of Tumour Virus Research is N/A.
  • It is published by Elsevier.
  • The journal is indexed in UGC CARE, Scopus, ESCI, DOAJ, PubMed.
  • It is an open access journal.
  • The (SJR) SCImago Journal Rank is 0.
  • The Tumour Virus Research is a reputed research journal.

Sources:

https://www.scopus.com/sourceid/21101038573







Similiar Journals


AIDS RESEARCH AND TREATMENT
ISSN: 2090-1240
Publisher: HINDAWI LTD

ARCHIVES OF CLINICAL INFECTIOUS DISEASES
ISSN: 2345-2641
Publisher: SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MED

CASE REPORTS IN INFECTIOUS DISEASES
ISSN: 2090-6625
Publisher: HINDAWI LTD

COMMUNICABLE DISEASES INTELLIGENCE
ISSN: 0725-3141
Publisher: AUSTRALIAN GOVERNMENT, DEPT HEALTH & AGEING

CURRENT FUNGAL INFECTION REPORTS
ISSN: 1936-3761
Publisher: SPRINGER

CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES
ISSN: 1523-3820
Publisher: SPRINGERNATURE

CURRENT TROPICAL MEDICINE REPORTS
ISSN: 2196-3045
Publisher: SPRINGER

GERMS
ISSN: 2248-2997
Publisher: EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES

HIV AIDS-RESEARCH AND PALLIATIVE CARE
ISSN: 1179-1373
Publisher: DOVE MEDICAL PRESS LTD

HIV & AIDS REVIEW
ISSN: 1730-1270
Publisher: TERMEDIA PUBLISHING HOUSE LTD

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.